Vsee Health Inc Receivables Turnover Ratio (VSEE), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vsee Health Inc   (NASDAQ: VSEE)
 

Vsee Health Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Vsee Health Inc 's ability to collect accounts receivable sequentially worsen to 3.84, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Vsee Health Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 95 days, from 81 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 417 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2357 to 2582.

What is Receivable Turnover Ratio?
What is Vsee Health Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VSEE Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change 37.07 % 39.46 % 25.68 % 80.86 % 8.7 %
Y / Y Revenue Change -39.66 % -23.14 % 1.72 % -8.38 % 51.24 %
Receivable Turnover Ratio (TTM) 3.84 4.48 5.14 5.44 6.47
VSEE's Total Ranking # 2582 # 2357 # 2059 # 1461 #
Accounts Receivable average collection period days 95 82 71 67 56
Seq. Receivable Change -14.66 % 5.62 % -1.32 % 54.11 % -13.17 %
Seq. Revenue Change -28.94 % -44.01 % 27.74 % 18.73 % -9.49 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 158
Healthcare Sector # 418
Overall Market # 2582

Receivable Turnover Ratio Statistics
High Average Low
12.73 7.81 4.3
(Sep 30 2024)   (Jun 30 2026)





VSEE Company Profile • Back to VSEE Efficiency Comparisons • Compare VSEE Receivables Turnover Ratio to its Competitors

Financial Statements
Vsee Health Inc 's Accounts Receivable $ 3 Millions Visit VSEE's Balance sheet
Vsee Health Inc 's Sales TTM $ 11 Millions Visit VSEE's Income Statement
Sources of VSEE's Revenues Visit VSEE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VSEE's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VSEE's Growth Rates VSEE's Roa VSEE's Inventory Turnover Ratio VSEE's Dividend Comparisons
VSEE's Profitability Ratios VSEE's Roi VSEE's Asset Turnover Ratio VSEE's Dividend Growth
VSEE's Valuation Ratios VSEE's Roe VSEE's Financial Strength Ratios VSEE's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Vaso Corporation  11.31 $ 80.220  Millions$ 7.094  Millions
Innoviva Inc   11.22 $ 420.630  Millions$ 37.491  Millions
Lifeloc Technologies Inc   11.19 $ 9.269  Millions$ 0.828  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Caredx Inc   10.81 $ 458.089  Millions$ 42.359  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Radnet Inc   10.53 $ 2,268.932  Millions$ 215.450  Millions
Kymera Therapeutics Inc   10.50 $ 105.000  Millions$ 10.000  Millions
Irhythm Holdings Inc   10.42 $ 825.702  Millions$ 79.250  Millions
Integrated Biopharma Inc  10.38 $ 42.568  Millions$ 4.101  Millions
Viemed Healthcare Inc   10.36 $ 301.606  Millions$ 29.102  Millions
Lensar Inc   10.33 $ 60.264  Millions$ 5.836  Millions
Immucell Corporation  10.30 $ 29.777  Millions$ 2.891  Millions
Addus Homecare Corp  10.25 $ 1,475.610  Millions$ 143.923  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions
Biodesix Inc   10.21 $ 102.939  Millions$ 10.081  Millions
Kestra Medical Technologies Ltd   10.00 $ 105.939  Millions$ 10.590  Millions
United Therapeutics Corporation  9.93 $ 3,154.500  Millions$ 317.550  Millions
Utah Medical Products Inc  9.88 $ 35.679  Millions$ 3.612  Millions
Biolife Solutions Inc   9.67 $ 102.718  Millions$ 10.626  Millions
The Oncology Institute Inc   9.66 $ 587.244  Millions$ 60.780  Millions
Sharps Technology Inc   9.65 $ 1.960  Millions$ 0.203  Millions
Encompass Health Corporation  9.57 $ 6,206.100  Millions$ 648.325  Millions
Septerna Inc   9.42 $ 98.882  Millions$ 10.501  Millions
Biofrontera Inc   9.33 $ 45.956  Millions$ 4.928  Millions
Enanta Pharmaceuticals Inc  9.29 $ 65.258  Millions$ 7.027  Millions

Date modified: 2026-10-15T05:23:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.